Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis - the p53 network.

Susan Haupt1, Michael Berger, Zehavit Goldberg

  • 1Department of Pharmacy, The Hebrew University Hadassah Medical School, Jerusalem 91120, Israel.

Journal of Cell Science
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors.

Blood cancer journal·2026
Same author

Editor's Note: Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53.

Cancer research·2026
Same author

Metabolic feedbacks drive population dynamics and can lead to oscillations among leaf bacteria.

Nature communications·2026
Same author

Thrombin is increased in diabetic retinal pathology in the STZ mice model, and its attenuation by a specific inhibitor, PARIN5, is associated with preserved function.

Scientific reports·2026
Same author

Post-treatment circulating tumor DNA clinical features, prognosis in HPV-positive oropharynx cancer.

Oral oncology·2026
Same journal

Potential role of myeloid bodies in protection against photo-oxidative damage of the retinal pigment epithelium.

Journal of cell science·2026
Same journal

From the FAZ to the TAC: Widespread cytoskeletal engagement of T. brucei KMP11.

Journal of cell science·2026
Same journal

Branched actin segregates endocytic cargo to control sorting and fission.

Journal of cell science·2026
Same journal

FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism.

Journal of cell science·2026
Same journal

Disentangling the response to lysosomal damage.

Journal of cell science·2026
Same journal

The force, form and function of the nucleus.

Journal of cell science·2026
See all related articles

The p53 tumor suppressor protein controls cell fate under stress, inducing either growth arrest or apoptosis. It utilizes multiple pathways, including extrinsic and intrinsic routes, to eliminate damaged cells, offering cancer therapy potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Cellular stress activates the p53 tumor suppressor, a transcription factor.
  • p53 regulates cell fate decisions, including growth arrest and apoptosis.
  • Apoptosis induction is crucial for preventing tumor formation.

Purpose of the Study:

  • To elucidate the diverse mechanisms by which p53 induces apoptosis.
  • To understand how p53 integrates signals to determine cell fate.
  • To explore the therapeutic potential of targeting p53-mediated apoptosis.

Main Methods:

  • Analysis of p53 target genes involved in apoptosis.
  • Investigation of extrinsic (death receptor) and intrinsic (mitochondrial) apoptotic pathways.
  • Examination of p53's transcription-dependent and independent roles in apoptosis.

Related Experiment Videos

Main Results:

  • p53 activates both extrinsic and intrinsic apoptotic pathways, converging through targets like Bid.
  • Apoptotic effects are mediated by gene induction and, in some cases, transcription-independent mechanisms.
  • p53's apoptotic functions are specific to cell type, stress, and signaling context.

Conclusions:

  • p53 employs a multifaceted strategy to ensure efficient apoptosis induction.
  • Understanding these mechanisms is key to developing p53-targeted cancer therapies.
  • Targeting p53's apoptotic functions presents a promising avenue for cancer treatment.